|
QPS successfully conducted two global Phase III trials for a biotech client in prostate cancer patients, focusing on efficacy, safety, and pharmacokinetics to expedite global approval applications.
The trials were managed across the USA, Europe, and Asia, involving the development of a new formulation for an existing prostate cancer treatment.
Despite the competitive market and stringent quality requirements, QPS delivered the studies on time with high data accuracy.
| 
